CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cardiol Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.10+0.00 (0.00%)
Close on Oct 19, 2026
Share price
+$0.07 (+6.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -0.39 CAD
- Free cash flow
- -C$23.88M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Seven years at a glance
Fiscal years 2019 to 2025, CAD
Revenue
–
Operating income
-C$34.32M
EPS, diluted
-0.39 CAD
Free cash flow
-C$23.88M
Reported period